An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Clinical trial NCT01582061 · COMPLETED
Trial details
- NCT number
- NCT01582061
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-16
- Primary completion
- 2017-01-26
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.